Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Targeting the 18-kDa translocator protein: recent perspectives for neuroprotection.
Disease-modifying agents in multiple sclerosis.
The Nogo/ Nogo-66 receptor (NgR) signal is involved in neuroinflammation through the regulation of microglia inflammatory mediator expression.
Frequency and relevance of IgM intrathecal synthesis in multiple sclerosis.
Pixantrone: a B-cell-depleting immunosuppressant for multiple sclerosis patients with active disease.
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers.
Impact of transcranial direct current stimulation on fatigue in multiple sclerosis.
Potential of Urinary Metabolites for Diagnosing Multiple Sclerosis.
Decoding movement intent of patient with multiple sclerosis for the powered lower extremity exoskeleton.
Intravenous administration of bone marrow-derived mesenchymal stem cells induces a switch from classical to atypical symptoms in experimental autoimmune encephalomyelitis.
The New England Journal of Medicine publishes pivotal data demonstrating efficacy and safety of oral BG-12 (dimethyl fumarate) in multiple sclerosis.
Role of regulatory T cells in pathogenesis and biological therapy of multiple sclerosis.
MOG-induced experimental autoimmune encephalomyelitis in the rat species triggers anti-neurofascin antibody response that is genetically regulated.
Biochemical Pharmacology of the Sigma-1 Receptor.
Clinical Characteristics and Urodynamic Analysis of Urinary Dysfunction in Multiple Sclerosis.
PD-1 Interaction with PD-L1 but not PD-L2 on B-cells Mediates Protective Effects of Estrogen against EAE.
Intermittent alien hand syndrome and callosal apraxia in multiple sclerosis: implications for interhemispheric communication.
High-Throughput Screening Platform for the Discovery of New Immunomodulator Molecules from Natural Product Extract Libraries.
Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis.
Demyelinating disease: Novel markers for disease severity in neuromyelitis optica.
Acute disseminated encephalomyelitis: current knowledge and open questions.
Anti-myelin antibodies play an important role in the susceptibility to develop PLP-induced EAE.
Misdiagnosis of multiple sclerosis: frequency, causes, effects, and prevention.
Hunting for autoantibodies in multiple sclerosis.
Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
Pages
« first
‹ previous
…
532
533
534
535
536
537
538
539
540
…
next ›
last »